Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections

51 - 74 of 74 Items

Research paper2022, jun 29

Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer

Ilknur Kucukosmanoglu, Meryem Ilkay Eren Karanis, Yasar Unlu, Mustafa Erol

Vol 25, No 2 (2022)

Research paper

Pubmed: 36047292
Nucl. Med. Rev 2022;25(2):73-77.
Review paper2022, jun 28

Myocardial perfusion imaging using single-photon emission computed tomography with cadmium-zinc-telluride technology

Sonia J. Konsek-Komorowska, Mariola Peczkowska, Jaroslaw B. Cwikła

Vol 25, No 2 (2022)

Review paper

Pubmed: 35848537
Nucl. Med. Rev 2022;25(2):119-126.
Research paper2022, jun 27

Sensitivity and specificity of nuclear medicines (DTPA and DMSA) with magnetic resonance imaging in diagnosing bone metastasis

Shoaa G. Shetewi, Jaber Alyami, Bander S. Al Mutairi, Saeed M. Bafaraj

Vol 25, No 2 (2022)

Research paper

Pubmed: 35848548
Nucl. Med. Rev 2022;25(2):85-88.
Letter to the Editor2022, jun 27

A 4.000 € way to improve perceived quality and meet expectations of thyroid cancer patients receiving therapeutic dose of Iodine-131

Evanthia Giannoula, Christos Melidis, Nikitas Papadopoulos, Panagiotis Bamidis, Vasilios Raftopoulos, Vasiliki Chatzipavlidou, Ioannis Iakovou

Vol 25, No 2 (2022)

Letter to the Editor

Pubmed: 36047293
Nucl. Med. Rev 2022;25(2):138-140.
Clinical vignette2022, jun 22

A crying liver: a scan pattern mimicking spontaneous perforation of the biliary ducts

Somaye Barashki, Hadis Mohammadzadeh Kosari, Emran Askari, Zahra Bakhshi Golestani, Mehran Hiradfar, Ramin Sadeghi

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 36047299
Nucl. Med. Rev 2022;25(2):131-133.
Clinical vignette2022, jun 21

Amino acid extravasation: a rare red flag to keep in mind during peptide receptor radioligand therapy (PRRT) with [177Lu]Lu-DOTATATE

Ghasemali Divband, Seyed Hootan Alavi, Zohre Adinehpour, Forough Kalantari, Soroush Zarehparvar Moghadam

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 35848524
Nucl. Med. Rev 2022;25(2):136-137.
Research paper2022, jun 21

[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?

Francesco Dondi, Domenico Albano, Francesco Bertagna, Raffaele Giubbini

Vol 25, No 2 (2022)

Research paper

Pubmed: 35848529
Nucl. Med. Rev 2022;25(2):78-84.
Clinical vignette2022, jun 9

99mTc-Vitamin C SPECT/CT imaging in SARS-CoV-2 associated pneumonia

Haluk B. Sayman, Kubra N. Toplutas, James Tunick, Omer Aras

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 35699590
Nucl. Med. Rev 2022;25(2):127-128.
Clinical vignette2022, jun 9

Radiopharmaceutical for detecting PSMA — positive metastatic colon cancer: Matched-pair comparison of 18F-BF3-Cy3-ACUPA and 68Ga-PSMA PET/MRI

Omer Aras, Cetin Demirdag, Harikrishna Kommidi, Richard Ting, Haluk B. Sayman

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 35699591
Nucl. Med. Rev 2022;25(2):129-130.
Editorial2022, jan 31

Editorial Note

Grzegorz Kamiński

Vol 25, No 1 (2022)

Editorial

Nucl. Med. Rev 2022;25(1).
Research paper2022, jan 31
Research paper2022, jan 31

Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset Lewy body disease

Yukinori Okada, Makoto Shiraishi, Koji Hori, Keiichro Yamaguchi, Yasuhiro Hasegawa

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137933
Nucl. Med. Rev 2022;25(1):18-24.
Research paper2022, jan 31

Degree of agreement between dacryoscintigraphy and dacryocystography examinations results in primary acquired nasolacrimal duct obstruction

Elyas Aditya, Yunia Irawati, Benny Zulkarnaien, Joedo Prihartono

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137932
Nucl. Med. Rev 2022;25(1):12-17.
Research paper2022, jan 31

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm

Barbara Bober, Marek Saracyn, Arkadiusz Lubas, Maciej Kolodziej, Dorota Brodowska-Kania, Waldemar Kapusta, Grzegorz Kaminski

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137938
Nucl. Med. Rev 2022;25(1):54-61.
Research paper2022, jan 27

The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial

Soudabe Alidadi, Ali Shabestani Monfared, Mehrangiz Amiri, Ebrahim Zabihi, Ehsan Assadollahi, Amir Gholami, Zoleika Moazezi, Zeinab Abedian

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137935
Nucl. Med. Rev 2022;25(1):31-36.
Clinical vignette2022, jan 27
Research paper2022, jan 26

Detection of a second primary cancer in a 18F-fluorocholine PET/CT – multicentre retrospective analysis on a group of 1345 prostate cancer patients

Paulina Cegla, Katarzyna Scibisz-Dziedzic, Kamila Witkowska, Anna Kubiak, Ewa Wierzchoslawska, Witold Kycler, Beata Chrapko, Rafał Czepczyński

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137934
Nucl. Med. Rev 2022;25(1):25-30.
Clinical vignette2022, jan 26

Hybrid bone SPECT/CT reveals spleen calcification in sickle cell mutation and beta-thalassemia

Konstantinos Sakellariou, Sofia Charalampidou, Andreas Fotopoulos, Chrissa Sioka

Vol 25, No 1 (2022)

Clinical vignette

Pubmed: 35137943
Nucl. Med. Rev 2022;25(1):70-71.
Clinical vignette2022, jan 24

Efficacy of long-term ultrasonography in follow-up of patients with papillary thyroid carcinoma: a case of neck metastasis developed 19 years following primary treatment

Vlatka Jozanovic, Sanja Kusacic Kuna, Marija Despot, Tatjana Samardzic, Drazen Huic

Vol 25, No 1 (2022)

Clinical vignette

Pubmed: 35137939
Nucl. Med. Rev 2022;25(1):62-63.
Research paper2022, jan 20

Optimal activity of [18F]FDG for Hodgkin lymphoma imaging performed on PET/CT camera with BGO crystals

Miroslaw Dziuk, Ewa Witkowska-Patena, Agnieszka Gizewska, Andrzej Mazurek, Anna Pieczonka, Magdalena Koza, Marina Gerszewska, Zbigniew Podgajny, Marta Chojnowska

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137937
Nucl. Med. Rev 2022;25(1):47-53.
Clinical vignette2022, jan 20

Rare osteoarticular complications on [18F]FDG-PET/CT — following intravesical BCG immunotherapy for bladder cancer

Jan-Henning Schierz, Anke McLeod, Farzana Ali

Vol 25, No 1 (2022)

Clinical vignette

Pubmed: 35137942
Nucl. Med. Rev 2022;25(1):68-69.
Clinical vignette2022, jan 19

Different glucose metabolism behavior relating to histotypes in synchronous breast cancers evaluated by [18F]FDG PET-CT

Pietro Bellini, Domenico Albano, Francesco Dondi, Francesco Bertagna, Raffaele Giubbini

Vol 25, No 1 (2022)

Clinical vignette

Pubmed: 35137940
Nucl. Med. Rev 2022;25(1):64-65.
Research paper2022, jan 18
Research paper2022, jan 14

Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ

Ismet Sarikaya, Ali Sarikaya, Ahmed N. Albatineh, Ebru Tastekin, Yavuz Atakan Sezer

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137931
Nucl. Med. Rev 2022;25(1):6-11.